✦ LIBER ✦

W1755 Blockade of Insulin-Like Growth Factor-I Receptor Is a Useful Anticancer Therapeutic for Esophageal Squamous Cell Carcinoma

✍ Scribed by Yamamoto, Hiroyuki; Adachi, Yasushi; Miyamoto, Nobuki; Miyamoto, Chie; Nosho, Katsuhiko; Taniguchi, Hiroaki; Maehata, Tadateru; Yamashita, Kentaro; Arimura, Yoshiaki; Itoh, Fumio; Imai, Kohzoh; Shinomura, Yasuhisa

Book ID: 123099181
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 68 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63310-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dual inhibition of epidermal growth fact

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

✍ Chad E. Galer; Christina L. Corey; Zhuoying Wang; Maher N. Younes; Fernando Gome 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

## Abstract ## Background Cutaneous squamous cell carcinoma (CSCC) is the second most common nonmelanoma skin cancer. Most of the approximately 250,000 cases occurring annually in the United States are small, nonaggressive, and cured by excision alone. However, a subset of these tumors which are d

Insulin-like growth factor-I receptor bl

Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45

✍ Hua Li; Yasushi Adachi; Hiroyuki Yamamoto; Yongfen Min; Hirokazu Ohashi; Masanor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

The High Expression of Epidermal Growth

The High Expression of Epidermal Growth Factor Receptor (EGFR) Is an Indicator for Poor Prognosis, Although It Is a Potential Indicator for Positive Outcome of Postoperative Radiation Therapy for Esophageal Squamous Cell Carcinoma

✍ Liu, X.; Xiao, Z.; Zhu, H.; Wang, Q.; Zhang, W.; Zhang, X.; He, J.; Chen, D.; Zh 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Requirement of different signaling pathw

Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line

✍ Huiyan Zeng; Kaustubh Datta; Matthias Neid; Jinping Li; Sareh Parangi; Debabrata 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Prevention of cytokine-induced apoptosis

Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells–evidence for a NF-κB-dependent survival mechanism

✍ Garrouste, F; Remacle-Bonnet, M; Fauriat, C; Marvaldi, J; Luis, J; Pommier, G 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

9013 POSTER DISCUSSION Phase I Dose-esca

9013 POSTER DISCUSSION Phase I Dose-escalation Study of AXL1717: a Novel Targeted Oral Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitor and Its Implications for Patients With Non-small Cell Lung Carcinoma

✍ Ekman, S.; Harmenberg, J.; Stáhl, B.; Hedlund, A.; Bergström, S.; Frodin, J.; Be 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB